['autism']
['l1-79', 'placebo']

        Inclusion Criteria:

          1. Males who are not sexually active

          2. 13 and 21 years of age

          3. Signed informed consent

          4. Normal clinical laboratory values

          5. DSM-5 compliant diagnosis of autism spectrum disorder, confirmed by the Autistic
             Diagnosis Interview Review (ADIR), and by the Autism Diagnosis Observation Schedule
             (ADOS) score consistent with a diagnosis of autism

          6. No more than one concomitant medication for the treatment of autism, on a stable for
             at least 2 weeks prior to enrollment and no planned changes in psychosocial
             interventions during the trial

          7. No medications for any other pathology

        Exclusion Criteria:

          1. Any co-morbidities, including Fragile-X syndrome, epilepsy, Retts syndrome, ADHD, or
             other disease or syndrome aside from autism that requires treatment

          2. Any other psychiatric disorder, or out of range lab values

          3. DSM-5 diagnosis of schizophrenia, schizoaffective disorder, alcohol use disorder

          4. Active medical problems: unstable seizures (>2 in past month)

          5. Concomitant physical illness
      